No-Flush Niacin 400 mg
80/100
This product is generally safe
- Niacin: 400mg is 11.4× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 400mg is 11.4× the Tolerable Upper Intake Level (35mg)
Label Data
1 Capsule(s)
Serving Size
Other Combinations
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
400 mg
(2500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 11.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
100 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
Other Ingredients
Capsule
Rice powder
Magnesium Stearate
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Suggested use: As a dietary supplement, adults take one capsule, one (1) to two (2) times daily with meals, or as directed by a healthcare professional.
⚠️ Warnings & Precautions
Keep out of reach of children.
🧪 Formulation Notes
(Inositol hexanicotinate)
Contains no sugar, salt, dairy, yeast, wheat, gluten, corn, soy, preservatives, artificial colors or flavors.
Our No-Flush Niacin will not cause the flush that is commonly associated with niacin use. It is derived from the finest inositol hexanicotinate available.
Quality and potency guaranteed
Additional Information
Store in a cool, dry place and away from direct light.
New day. Fresh start. Better health.
Product Details
UPC / SKU
7 87500 03151 1
DSLD Entry Date
2020-06-24
Product Type
Other Combinations
Form
Capsule
Brand
CHK Nutrition
DSLD ID
228537
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100